Therapeutic drug monitoring as a tool in treating HIV infection

被引：28

作者：

Khoo, SH ^{[1
]}

Gibbons, SE ^{[1
]}

Back, DJ ^{[1
]}

机构：

[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool HIV Pharmacol Grp, Liverpool L69 3GE, Merseyside, England

来源：

AIDS | 2001年 / 15卷

关键词：

therapeutic drug monitoring; HIV; protease inhibitors; non-nucleoside reverse transcriptase inhibitors;

D O I：

10.1097/00002030-200100005-00021

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：S171 / S181

页数：11

共 61 条

[31] The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy [J].

Hoetelmans, RMW ;

Reijers, MHE ;

Weverling, GJ ;

ten Kate, RW ;

Wit, FWNM ;

Mulder, JW ;

Weigel, HM ;

Frissen, PHJ ;

Roos, M ;

Jurriaans, S ;

Schuitemaker, H ;

de Wolf, F ;

Beijnen, JH ;

Lange, JMA .

AIDS, 1998, 12 (11) :F111-F115

[32]

Hsu A, 2000, AIDS, V14, pS12

[33] Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects [J].

Hsu, A ;

Granneman, GR ;

Witt, G ;

Locke, C ;

Denissen, J ;

Molla, A ;

Valdes, J ;

Smith, J ;

Erdman, K ;

Lyons, N ;

Niu, P ;

Decourt, JP ;

Fourtillan, JB ;

Girault, J ;

Leonard, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :898-905

[34]

Hsu A, 2001, 8 C RETR OPP INF CHI

[35]

JOSHI AS, 1999, 39 INT C ANTI AG CHE

[36]

KEMPF D, 2001, 8 C RETR OPP INF CHI

[37]

KERR B, 1998, 12 INT C AIDS GENEVA

[38] Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease [J].

Khaliq, Y ;

Gallicano, K ;

Seguin, I ;

Fyke, K ;

Carignan, G ;

Bulman, D ;

Badley, A ;

Cameron, DW .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (02) :108-115

[39]

KLINE MW, 1998, 12 INT C AIDS GEN JU

[40] Ritonavir [J].

Lea, AP ;

Faulds, D .

DRUGS, 1996, 52 (04) :541-546

← 1 2 3 4 5 6 7 →